Applying Functional Medicine Using A Novel Plant-based Source of Essential Fatty Acids in the Treatment of Migraines Headaches; 2 Case Studies
Abstract
Objective: To report on 2 case studies of migraine patients effectively treated using a functional medicine approach, including the use of a broad spectrum, plant-based nutraceutical of essential fatty acids, cranial stimulation and botox injections.
Settings: Headache, Migraine and Pain Treatment Centre, 555 Kingston Rd W, Ajax, Ontario.
Subjects: Patients with migraines referred from family physicians. Patients were pre-screened with a Migraine Disability Score (MIDAS).
Outcome measures: MIDAS questionnaire, functional blood tests, imaging and physical examination including neurological and orthopedic assessment.
Interventions: The first case was treated with a plant based, broad spectrum Omega fatty acid formula, Cranial-Electrical Stimulation with Audiovisual Entrainment daily and for botox therapy. The second patient received the Omega formula exclusively. Concomitant medications and therapies were also adjusted or discontinued. Duration of treatment varied from 1 to 6 months.
Results: These patients improved significantly in most outcome measures. In all cases drug use was eliminated or substantially reduced. No major adverse reaction, habituation or tolerance developed. Quality of life was also improved subjectively as per patient report.
Keywords
Full Text:
Subscribers OnlyReferences
http://www.statcan.gc.ca/pub/82-003-x/2014006/article/14033-eng.htm
http://www.mayoclinic.org/diseases-conditions/migraine-headache/home/ovc-20202432
Adelman, James U., and Richard D. Adelman. “Current Options for the Prevention and Treatment of Migraine.” Clinical Therapeutics 23, no. 6 (June 1, 2001): 772–88. doi:10.1016/S0149-2918(01)80069-2.
Ducharme, James. “Canadian Association of Emergency Physicians Guidelines for the Acute Management of Migraine Headache.” The Journal of Emergency Medicine 17, no. 1 (1999): 137–144.
Negro, Andrea, and Paolo Martelletti. “Chronic Migraine plus Medication Overuse Headache: Two Entities or Not?” The Journal of Headache and Pain 12, no. 6 (December 2011): 593–601. doi:10.1007/s10194-011-0388-3.
https://www.functionalmedicine.org/What_is_Functional_Medicine/AboutFM
Serotonin metabolism in migraine. M. D. Ferrari, MD et al. Neurology September 1989 vol. 39 no. 9 1239
Jan Lewis Brandes, MD The Influence of Estrogen on Migraine. A Systematic Review. Article Information Clinical Review Section Editor: Michael S. Lauer, MD. We encourage authors to submit papers for consideration as a Clinical Review. Please contact Michael S. Lauer, MD, at [email protected].
Author Affiliations: Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tenn; and Nashville Neuroscience Group.
JAMA. 2006;295(15):1824-1830. doi:10.1001/jama.295.15.1824
Saxena, P. R. and et al. Role of some biogenic substances in migraines and relevant mechanism in antimigraine action of ergotamine-studies in an experimental model for migraine. Headache: The Journal of Head and Face Pain, 13: 142–163. doi:10.1111/j.1526-4610.1974.hed1304142.x
Bob Weinhold; Epigenetics: The Science of Change. Environ Health Perspect. 2006 Mar; 114(3): A160–A167.
https://www.functionalmedicine.org
Calder PC. Immunomodulation by Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2007;77:327–335.
Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr. 2004;24:345-376.
Lee JH, O’Keefe JH, Lavie CJ, et.al. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83:324–332.
Orr SK, Bazinet RP. DHA playing an unexpected role in neurogenic inflammation. Curr Opin Investig Drugs. 2008 Jul;9(7):735-43.
Christopher E. Ramsden et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: A randomized trial. Pain; Volume 154, Issue 11, November 2013, Pages 2441–2451.
M. Elizabeth Sublette, MD, PhD; Steven P. Ellis, PhD; Amy L. Geant, BA; and J. John Mann, MD
Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression. J Clin Psychiatry 2011;72(12):1577-1584
Heiner C Bucher, MD, MPH et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. The American Journal of Medicine Volume 112, Issue 4, March 2002, Pages 298–304.
Robert J. Goldberg, Joel Katz. A meta-analysis of the analgesic effects of Omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain; Volume 129, Issues 1–2, May 2007, Pages 210–223.
Michael H. Bloch, M.D., M.S., Ahmad Qawasmi, M.D. Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis. Journal of the American Academy of Child & Adolescent Psychiatry Volume 50, Issue 10, October 2011, Pages 991–1000.
Zeev Harel, M.D. et al. Supplementation with Omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. Journal of Adolescent Health Volume 31, Issue 2, August 2002, Pages 154–161.
Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Neurological influences of EFAs. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):12-26. Epub 2006 Aug 28.
Caramia G. Biochemical influence of EPAs. Minerva Pediatr. 2008 Aug;60(4):443-455. Omega-3: from cod-liver oil to nutrigenomics.
Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003;126(1):1-27.
Caramia G. Biochemical influence of EPAs. Minerva Pediatr. 2008 Aug;60(4):443-455. Omega-3: from cod-liver oil to nutrigenomics.
Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot Essent Fatty Acids. 2003 Mar;68(3):219-24.
http://www.gustrength.com/health:omega-3-fatty-acids-and-inflammation
DOI: http://dx.doi.org/10.18103/imr.v3i2.331
Refbacks
- There are currently no refbacks.